Maven Securities LTD - REGENERON PHARMACEUTICALS ownership

REGENERON PHARMACEUTICALS's ticker is and the CUSIP is 75886F957. A total of 7 filers reported holding REGENERON PHARMACEUTICALS in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Maven Securities LTD ownership history of REGENERON PHARMACEUTICALS
ValueSharesWeighting
Q3 2023$329,184
-87.6%
400
-89.2%
0.00%
-90.0%
Q2 2023$2,659,317
+709.1%
3,700
+825.0%
0.04%
+471.4%
Q1 2023$328,668
-8.9%
400
-20.0%
0.01%
-12.5%
Q4 2022$360,745
-83.1%
500
-83.9%
0.01%
-79.5%
Q3 2022$2,136,000
+22.3%
3,100
+24.0%
0.04%
-36.1%
Q1 2022$1,746,000
+2.4%
2,500
-7.4%
0.06%
+24.5%
Q4 2021$1,705,000
+156.0%
2,700
+145.5%
0.05%
+133.3%
Q3 2021$666,000
-63.9%
1,100
-66.7%
0.02%
-71.6%
Q2 2021$1,843,000
+224.5%
3,300
+175.0%
0.07%
+196.0%
Q1 2021$568,000
-33.3%
1,200
-20.0%
0.02%
-64.3%
Q3 2020$851,000
-9.0%
1,5000.0%0.07%
+9.4%
Q2 2020$935,0001,5000.06%
Other shareholders
REGENERON PHARMACEUTICALS shareholders Q3 2021
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 2,198$80,686,0004.69%
SIMPLEX TRADING, LLC 1,029$1,326,0000.08%
Allianz Asset Management GmbH 205,300$75,364,0000.07%
Timber Hill LLC 22,300$8,186,0000.04%
View complete list of REGENERON PHARMACEUTICALS shareholders